Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. - Tomioka,N.; Oba,S.; Ohira,M.; Misra,A.; Fridlyand,J.; Ishii,S.; Nakamura,Y.; Isogai,E.; Hirata,T.; Yoshida,Y.; Todo,S.; Kaneko,Y.; et al. (Oncogene, 2008)